| Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study JP Collet, JS Hulot, A Pena, E Villard, JB Esteve, J Silvain, L Payot, ... The Lancet 373 (9660), 309-317, 2009 | 1246 | 2009 |
| Bedside monitoring to adjust antiplatelet therapy for coronary stenting JP Collet, T Cuisset, G Rangé, G Cayla, S Elhadad, C Pouillot, P Henry, ... New England Journal of Medicine 367 (22), 2100-2109, 2012 | 1055 | 2012 |
| Pretreatment with prasugrel in non–ST-segment elevation acute coronary syndromes G Montalescot, L Bolognese, D Dudek, P Goldstein, C Hamm, JF Tanguay, ... New England Journal of Medicine 369 (11), 999-1010, 2013 | 745 | 2013 |
| Prehospital ticagrelor in ST-segment elevation myocardial infarction G Montalescot, AW Van't Hof, F Lapostolle, J Silvain, JF Lassen, ... New England Journal of Medicine 371 (11), 1016-1027, 2014 | 727 | 2014 |
| Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19* 2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta … JS Hulot, JP Collet, J Silvain, A Pena, A Bellemain-Appaix, O Barthélémy, ... Journal of the American College of Cardiology 56 (2), 134-143, 2010 | 524 | 2010 |
| Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French Registry of Acute ST … E Puymirat, T Simon, G Cayla, Y Cottin, M Elbaz, P Coste, G Lemesle, ... Circulation 136 (20), 1908-1919, 2017 | 483 | 2017 |
| Composition of coronary thrombus in acute myocardial infarction J Silvain, JP Collet, C Nagaswami, F Beygui, KE Edmondson, ... Journal of the American College of Cardiology 57 (12), 1359-1367, 2011 | 438 | 2011 |
| Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis JP Collet, Y Allali, C Lesty, ML Tanguy, J Silvain, A Ankri, B Blanchet, ... Arteriosclerosis, thrombosis, and vascular biology 26 (11), 2567-2573, 2006 | 407 | 2006 |
| Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label … G Montalescot, U Zeymer, J Silvain, B Boulanger, M Cohen, P Goldstein, ... The Lancet 378 (9792), 693-703, 2011 | 391 | 2011 |
| Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial G Montalescot, G Cayla, JP Collet, S Elhadad, F Beygui, H Le Breton, ... Jama 302 (9), 947-954, 2009 | 366 | 2009 |
| Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised … G Cayla, T Cuisset, J Silvain, F Leclercq, S Manzo-Silberman, ... The Lancet 388 (10055), 2015-2022, 2016 | 363 | 2016 |
| Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial JP Collet, J Silvain, O Barthélémy, G Rangé, G Cayla, E Van Belle, ... The Lancet 384 (9954), 1577-1585, 2014 | 320 | 2014 |
| Optical coherence tomography to optimize results of percutaneous coronary intervention in patients with non–ST-elevation acute coronary syndrome: results of the multicenter … N Meneveau, G Souteyrand, P Motreff, C Caussin, N Amabile, P Ohlmann, ... Circulation 134 (13), 906-917, 2016 | 315 | 2016 |
| Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis J Silvain, F Beygui, O Barthélémy, C Pollack, M Cohen, U Zeymer, ... Bmj 344, 2012 | 277 | 2012 |
| Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis G Cayla, JS Hulot, SA O’Connor, A Pathak, SA Scott, Y Gruel, J Silvain, ... Jama 306 (16), 1765-1774, 2011 | 266 | 2011 |
| Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic … A Bellemain-Appaix, SA O’Connor, J Silvain, M Cucherat, F Beygui, ... Jama 308 (23), 2507-2516, 2012 | 247 | 2012 |
| Multivessel PCI guided by FFR or angiography for myocardial infarction E Puymirat, G Cayla, T Simon, PG Steg, G Montalescot, I Durand-Zaleski, ... New England Journal of Medicine 385 (4), 297-308, 2021 | 224 | 2021 |
| Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study G Montalescot, B Pitt, E Lopez de Sa, CW Hamm, M Flather, F Verheugt, ... European heart journal 35 (34), 2295-2302, 2014 | 195 | 2014 |
| High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2) JP Collet, JS Hulot, G Anzaha, A Pena, T Chastre, C Caron, J Silvain, ... JACC: Cardiovascular Interventions 4 (4), 392-402, 2011 | 183 | 2011 |
| Periprocedural myocardial infarction and injury in elective coronary stenting M Zeitouni, J Silvain, P Guedeney, M Kerneis, Y Yan, P Overtchouk, ... European heart journal 39 (13), 1100-1109, 2018 | 181 | 2018 |
kerneis mathieuCardiology, Hôpital de la Pitié-Salpétrière, AP-HPVerified email at psl.aphp.fr
